key: cord-1035037-rw226lu7
authors: Kario, Kazuomi; Chia, Yook‐Chin; Siddique, Saulat; Turana, Yuda; Li, Yan; Chen, Chen‐Huan; Nailes, Jennifer; Huynh, Minh Van; Buranakitjaroen, Peera; Cheng, Hao‐Min; Fujiwara, Takeshi; Hoshide, Satoshi; Nagai, Michiaki; Park, Sungha; Shin, Jinho; Sison, Jorge; Soenarta, Arieska Ann; Sogunuru, Guru Prasad; Sukonthasarn, Apichard; Tay, Jam Chin; Teo, Boon Wee; Tsoi, Kelvin; Verma, Narsingh; Wang, Tzung‐Dau; Zhang, Yuqing; Wang, Ji‐Guang
title: Seven‐action approaches for the management of hypertension in Asia – The HOPE Asia network
date: 2022-02-16
journal: J Clin Hypertens (Greenwich)
DOI: 10.1111/jch.14440
sha: fe07e03c27c5617f757705b1325d00eb3e24e564
doc_id: 1035037
cord_uid: rw226lu7

Asia is a large continent and there is significant diversity between countries and regions. Over the last 30 years, absolute blood pressure (BP) levels in Asia have increased to a greater extent than those in other regions. In diverse Asia‐Pacific populations, for choosing an Asia‐specific approach to hypertension management is important to prevent target organ damage and cardiovascular diseases. In this consensus document of HOPE Asia Network, we introduce seven action approaches for management of hypertension in Asia.

Asia is a large continent and, along with Asia-specific features of hypertension, there is also significant diversity between countries and regions within the continent. 1, 2 Over the last 30 years, absolute blood pressure (BP) levels in Asia have increased to a greater extent than those in other regions, such that these are amongst the highest in the world. 1 In addition, the proportion of individuals with hypertension who achieve BP control is relatively low in Asian countries/regions compared with the US, Canada and Europe. 3, 4 Again, statistics for Asia are notable for their heterogeneity, with large variations in rates of hypertension awareness, treatment and control throughout the continent. [4] [5] [6] Potential explanation for this may be differences in genetic background, diet, lifestyle, and sociodemographic factors in the region, 7 where there are various factors that contribute to the development of hypertension and cardiovascular disease. 8 In most Asian countries, common risk factors for hypertension include obesity, sedentary lifestyles, alcohol intake, higher socioeconomic status, high salt intake, diabetes mellitus, and smoking. Lower social class is also a risk factor for hypertension in Japan (and the Asia-Pacific countries of Australia, and New Zealand), while continued high smoking rates are an issue in China and several other Asian countries. 9 Another important reason for choosing an Asia-specific approach to hypertension management is the differential impact of hypertension on target organ damage in diverse Asia-Pacific populations. The asso-ciation between BP and cardiovascular disease has been shown to be stronger in East Asian individuals compared with those from Australia or New Zealand. 10 There was also higher prevalence of hypertension in stroke patients from South Asia compared with China in a populationbased analysis. 11 

The Hypertension Cardiovascular Outcome Prevention and Evidence in Asia (HOPE Asia) Network's Asia BP@Home study investigated BP control status in eleven Asian countries/regions. 5 It was the first study of home BP control status to utilize the same home BP monitoring (HBPM) device and measurement protocol for all patients and study centers. 5 Overall, 53.6% of medicated patients with hypertension were well controlled for morning home systolic BP (SBP; < 130 mmHg -the 2017 AHA/ACC threshold 12 ). However, there were marked differences in home BP control status between countries/regions; these were highest in the Philippines, Korea, Japan, Pakistan, Thailand, and Taiwan, and lowest in China and Indonesia. 5 In a subanalysis of the Asia BP@Home study, both office and home heart rates in patients from South Asia were higher than those in other Asian countries (by ≥5 beats/min), even after controlling for demographics and beta-blocker use. 13 Given what is known about the impact of heart rate on heart disease, our findings suggest a possible benefit of regionally tailored clinical strategies for cardiovascular disease prevention, such as the use of beta-blockers. Comparing the ambulatory BP monitoring (ABPM) data from Japan and Thailand also shows significant between country differences in the BP profile. 14 Even when office BP was comparable, a non-dipper/riser pattern of nighttime BP was more common in patients from Thailand, while morning BP surge was higher in those from Japan. Furthermore, even within the same county, there were rural and urban disparities in BP control status in Asia, partly due to the differences in the uptake of a western diet and lifestyle. 14 

The HOPE Asia Network was set up to improve the management of hypertension in Asia with the goal of achieving "zero" cardiovascular events in the region. 15 Asian evidence and guidelines have been discussed by Network members to reach consensus on key topics such as target BP level, practical application of HBPM and ABPM, salt intake and preferred antihypertensive medications, among others, resulting in the publication of a number of consensus documents and Asiaspecific recommendations that cover nearly all major topics relating to the management of hypertension. [15] [16] [17] [18] [19] [20] These documents should contribute to optimizing individual and population-based hypertension management strategies in Asian countries/regions. 20 The HOPE Asia Network model is an excellent example of how interpretation, modification, and dissemination of international best practices at a regional level, in collaboration with local hypertension societies, can be used to benefit specific populations. The HOPE Asia Data from studies involving 49 countries demonstrated that there is a U-shape relationship between salt consumption and cardiovascular events. 26 In patients with hypertension, sodium intake of > 6 g/day is associated with higher risk of cardiovascular disease and death. 26 In addition, a nationwide study conducted in Japan showed that higher household salt intake was associated with long-term all-cause and cardiovascular mortality. 27 In 2017, WHO designated "sodium intake reduction" as a "best buy"

to avoid premature deaths and reduce the economic impact of noncommunicable diseases in low-and middle-income countries. 28 Most successful programs include multi-component strategies.

One simple and effective way to reduce salt intake is the complete or partial substitution of sodium chloride with potassium chloride. There is a good body of evidence, including that from the Salt Substitute and There are also many national-level programs in Asia designed to reduce population salt intake. These include the Chinese government's "Healthy Lifestyle for All" program (as part of China's health development agenda), 32 Salt Reduction," which included six strategies to achieve a target salt intake of < 6 g/day. 34 This was followed by The Okinawa Declaration on the unity of hypertension societies in Asian countries and regions to overcome hypertension and hypertension-related diseases, which was announced in 2021. 6 The National Health and Nutrition Survey of Japan provides an indication of the impact of these programs. The data showed that sodium A higher urinary sodium-to-potassium (Na/K) ratio has been reported to be associated with high BP and subsequent cardiovascular events. 36 A urinary Na/K molar ratio of < 1 may be a useful indicator for adherence to the WHO-recommended levels of sodium. 37 Another important determinant of salt sensitivity is obesity, and Asian individuals can develop hypertension even when there is only a small increase in the body mass index (BMI). 38 In addition, the risk of prehypertension and hypertension develops at a lower BMI threshold than in Westerners (25 vs 30 kg/m 2 ). 38 Thus, body weight control, especially in younger and middle-aged adults, is important for Asians.

Previous studies have shown that the slope of the association between BP and cardiovascular events is steeper in Asians than Westerners. 39 Data from the recent STEP (Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients) trial, conducted in China, showed that strict BP control (SBP 110-130 mmHg) was superior to standard BP control (SBP 130-150 mmHg) for preventing cardiovascular events. 40 The findings of this study are relevant for hypertension management in Asia, [41] [42] [43] and suggest that elderly Asians would benefit from strict BP control to reduce cardiovascular risk.

A recent Blood Pressure Lowering Treatment Trialists' Collaboration (BPLTTC) meta-analysis, which includes data from the Systolic Blood Pressure Intervention Trial (SPRINT), has been released. 44 The results showed that a 5-mmHg reduction in office SBP reduced the risk of total cardiovascular disease by 10%, the risk of stroke and heart failure by 13%, and the risk of coronary artery disease by 8%. 44 In addition, these benefits of BP lowering were seen in individuals aged up to 85 years. 45 In the STEP study, a 5-mmHg reduction in office SBP was associated with an 18% reduction in total cardiovascular disease risk, a 23% reduction in the risk of stroke and coronary artery disease, and a 58% reduction in heart failure risk. These findings showing greater reductions in cardiovascular risk in the STEP study than in SPRINT and the BPLTTC ( Table 2 ), suggest that strict BP control is probably more effective for cardiovascular disease prevention in Asians than in Westerners. Based on data obtained using wearable BP monitoring devices, morning SBP measured in accordance with guideline recommenda-tions was most closely associated with left ventricular mass measured using cardiac magnetic resonance imaging in medicated patients with hypertension. 57 In addition, in the J-HOP Study, high morning SBP measured by using HBPM (especially SBP ≥135 mmHg) was stronger predictor of stroke than evening BP measured just before going to bed. 49 For high-risk patients with a history of stroke or diabetes, the pathological SBP threshold is lower, at about 125 mmHg. 58, 59 Another important feature of hypertension in Asian populations is high nighttime BP, which is commonly associated with high salt sensitivity and salt intake. Nocturnal hypertension, including isolated nocturnal hypertension with well-controlled office and/or morning BP, is a risk factor for organ damage and cardiovascular disease even. [60] [61] [62] [63] Nocturnal hypertension is often found in high-risk patients with comorbidities such as diabetes, chronic kidney disease and sleep apnea. 64, 65 Furthermore, high nighttime BP, especially the riser pattern of nocturnal BP, is a risk factor for the development of heart failure, 64, 66 and partly explains the higher B-type natriuretic peptide seen in hypertensive patients. 67 Another important consideration is sleep duration, which should be ≥6 hours, with control of nighttime BP, to reduce the risk of cardiovascular disease. 68 In cases where the patient's BP is uncertain or labile, or where there is nonadherence to HBPM, 24-hour ABPM is recommended for confirming the level of BP control. 18 Nocturnal HBPM devices are also clinically available. 60, 63 In addition, wrist-type nocturnal HBPM devices that cause less sleep disturbance have now been validated and are available for use in clinical practice. 69, 70 Thus, both ABPM and nocturnal HBPM are useful to detect nocturnal hypertension, especially in high-risk patients. [71] [72] [73] Seasonal changes in BP and vascular properties, especially home BP control status in relation to room temperature also need to be considered. [74] [75] [76] [77] [78] [79] [80] [81] [82] Morning BP increases to a greater extent in the winter (colder temperatures) and is associated with organ damage, while nighttime BP is increased in the summer (warmer temperatures). 81 Compared with evening home BP, morning home BP might be a better predictor of winter-onset cardiovascular events, 83 and the winter morning BP surge partly explains the increased risk of cardiovascular events in the winter. 84 Therefore, BP surges during winter should be an important target of a home BP-guided approach to hypertension management. 

Rates of hypertension awareness in some Asian countries/regions are low, meaning that strategies such as screening for hypertension in public places (eg, the workplace or COVID-19 vaccination centers), and self-measurement of BP using HBPM at home and/or at work might be useful. [103] [104] [105] As part of the May Measurement Month initiative, BP was measured in millions of people in several Asian countries/regions. 106 The prevalence of hypertension in screened populations was found to be 30.6% in East Asia and 47.8% in South-East Asia and Australasia; corresponding hypertension awareness rates were 59.0% and 66.5%. 106 Of patients with hypertension in Asia Pacific, only 16.8% to 28.6% were being treated with antihypertensive medication. Of those treated, more than one-third (33.4% in East Asia and 36.8% in South-East Asia and Australasia) had uncontrolled BP. 106 This reinforces the need for effective strategies to both diagnose and treat hypertension in the region.

The COVID-19 pandemic has increased the use of telemedicine strategies and means that telemedicine has become an increasingly popular and important option in Asia to ensure patient and physician safety and facilitate infection control. [107] [108] [109] A wearable BP monitoring device has been developed and validated, 110 and there is also an ABPM technology platform to facilitate diagnostic and treatment decisions without the need for an office visit. 108 In addition, telemedicine represents a useful approach to help deliver effective care to patients with hypertension, regardless of their location, in terms of monitoring BP, improving uptake of lifestyle recommendations and increasing medication adherence, all of which help to optimize disease management. 111 In the STEP trial, the study participants and physicians used the smartphone-based Hypertension Doctor App platform. 40 

Resistant hypertension, defined based on HBPM or ABPM, is a significant risk for cardiovascular disease, including heart failure. 115, 116 Renal denervation (RDN) is an alternative approach to treatment for patients with resistant hypertension that has potential in Asian populations. [117] [118] [119] [120] [121] One of the benefits of RDN is a sustained reduction in BP, and this can be used as an adjunct or alternative to antihypertensive drug therapy and/or digital therapeutics-guided lifestyle modifications. The optimal approach for each patient will best be determined based on a shared decision-making process based on patient preference and evidence-based recommendations from their physician. 123 There were no significant differences in the 24-hour BP-lowering effects of RDN between patients who were versus were not receiving antihypertensive medication, or between radiofrequency and ultrasound RDN devices. 123 However, in certain cases whose BP could not be controlled in spite of receiving a huge amount of antihypertensive drugs, RDN can be considered.

Early achievement and maintenance of 24-hour BP control includes three components: strict lowering of 24-hour BP; maintaining the dipper pattern of nocturnal BP; and maintenance of optimal BP variability.

These are essential to reduce and prevent hypertension-related target organ damage and associated diseases throughout the lifespan. 38 To facilitate the achievement of this goal, research and development of wearable BP monitoring devices is needed. 124 In the first study to compare BP values measured using a recently developed wristworn watch-type oscillometric BP monitoring (WBPM) device with those obtained using traditional ABPM, between-device differences in both office and out-of-office BP were acceptable. 110 In addition, BP measured using a wearable device has been shown to correlate with left ventricular mass. 57 The larger number of BP measurements provided by a wearable device could detect individual peak BP, and might add to the clinical value of these measurements, thus complementing guideline-recommended HBPM. "Cuff-less" approaches to BP monitoring are ideal, but this technology needs further evaluation for measurement of absolute BP before it can be used in clinical practice.

The benefits of effective BP lowering are greater in Asians than in Westerners. Therefore, antihypertensive strategies and action plans that take into account Asian characteristics should be shared and developed within and across the different and heterogeneous countries/regions in Asia. We hope that these seven action approaches from the HOPE Asia Network contribute to achieving the goal of "zero" cardiovascular events in Asia.

The authors thank Viatris for the grant to support the HOPE Asia Network activities.

K. Kario 

Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension

The healthcare burden of hypertension in Asia

Epidemiology of hypertension in Japan: beyond the new 2019 Japanese guidelines

Could 130/80 mm Hg Be Adopted as the Diagnostic Threshold and Management Goal of Hypertension in Consideration of the Characteristics of Asian Populations? Hypertension

Home blood pressure control status in 2017-2018 for hypertension specialist centers in Asia: results of the Asia BP@Home study

Statement of the Asian Hypertension Society Network: the Okinawa Declaration on the unity of hypertension societies in Asian countries and regions to overcome hypertension and hypertension-related diseases

Annual reports on hypertension research 2020

Diversity of and initiatives for hypertension management in Asia-Why we need the HOPE Asia Network

Hypertension and stroke in Asia: prevalence, control and strategies in developing countries for prevention

Effects of prehypertension and hypertension subtype on cardiovascular disease in the Asia-Pacific Region

Temporal trends in stroke incidence in South Asian, Chinese and white patients: a population based analysis

NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: executive Summary: a Report of the American College of Cardiology

Regional differences in office and self-measured home heart rates in Asian hypertensive patients: asiaBP@Home study

Differences in ambulatory blood pressure profiles between Japanese and Thai patients with hypertension /suspected hypertension

The HOPE Asia Network activity for "zero" cardiovascular events in Asia: overview 2020

Current status of home blood pressure monitoring in Asia: statement from the HOPE Asia Network

COVID-19 and hypertension-evidence and practical management: guidance from the HOPE Asia Network

Expert panel consensus recommendations for ambulatory blood pressure monitoring in Asia: the HOPE Asia Network

Expert panel consensus recommendations for home blood pressure monitoring in Asia: the Hope Asia Network

Consensus summary on the management of hypertension in Asia from the HOPE Asia Network

Global, regional and national sodium intakes in 1990 and 2010: a systematic analysis of 24 h urinary sodium excretion and dietary surveys worldwide

Salt sensitivity of Japanese from the viewpoint of gene polymorphism

World Health Organization. Global action plan for the prevention and control of NCDs

Institute for Public Health Malaysia. Determination of dietary sodium itake among the Ministry of Health staff

Salt Reduction Initiatives around the World -A Systematic Review of Progress towards the Global Target

Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies

Relationship of household salt intake level with long-term all-cause and cardiovascular disease mortality in Japan: nIPPON DATA80

World Health Organization Tackling NCDs: 'best buys' and other recommended interventions for the prevention and control of noncommunicable diseases

Effect of Salt Substitution on Cardiovascular Events and Death

Effects of a reduced-sodium addedpotassium salt substitute on blood pressure in rural Indian hypertensive patients: a randomized, double-blind, controlled trial

Efficacy of a digital therapeutics system in the management of essential hypertension: the HERB-DH1 pivotal trial

Action on Salt China" (ASC): protocol for Campaigns and Randomized Controlled Trials

Cost and cost-effectiveness of a school-based education program to reduce salt intake in children and their families in China

JSH Statement: tokyo declaration promoting salt reduction by the Japanese Society of Hypertension-the JSH Tokyo declaration

The Japanese Society of Hypertension Guidelines for the Management of Hypertension

Association of blood pressure with estimates of 24-h urinary sodium and potassium excretion from repeated single-spot urine samples

Urinary sodium-to-potassium ratio and intake of sodium and potassium among men and women from multiethnic general populations: the INTERSALT Study

Essential manual of perfect 24-hour blood pressure management from morning to nocturnal hypertension

The burden of blood pressure-related disease: a neglected priority for global health

Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension

STEP to estimate cardiovascular events by home blood pressure in the era of digital hypertension

Utility of the "Strategy of Blood Pressure Intervention in Elderly Hypertensive Patients" for home blood pressure management in a real-world setting

Step for breaking free from clinical inertia

Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis

Agestratified and blood-pressure-stratified effects of blood-pressurelowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis

Home Blood Pressure Monitoring: current Status and New Developments

Hypertension types defined by clinic and ambulatory blood pressure in 14143 patients referred to hypertension clinics worldwide. Data from the ARTEMIS study

Emergence of Home Blood Pressure-Guided Management of Hypertension Based on Global Evidence

Morning and Evening Home Blood Pressure and Risks of Incident Stroke and Coronary Artery Disease in the Japanese General Practice Population: the Japan Morning Surge-Home Blood Pressure Study

Day-by-Day Variability of Home Blood Pressure and Incident Cardiovascular Disease in Clinical Practice: the J-HOP Study (Japan Morning Surge-Home Blood Pressure)

Increased Arterial Stiffness Amplifies the Association Between Home Blood Pressure Variability and Cardiac Overload: the J-HOP Study

Impact of home blood pressure variability on cardiovascular outcome in patients with arterial stiffness: results of the J-HOP study

Difference between morning and evening home blood pressure and cardiovascular events: the J-HOP Study (Japan Morning Surge-Home Blood Pressure)

Clinical Impact of the Maximum Mean Value of Home Blood Pressure on Cardiovascular Outcomes: a Novel Indicator of Home Blood Pressure Variability

Guidance on home blood pressure monitoring: a statement of the HOPE Asia Network

Ethnic Differences in the Degree of Morning Blood Pressure Surge and in Its Determinants Between Japanese and European Hypertensive Subjects. Hypertension

Relationship between blood pressure repeatedly measured by a wristcuff oscillometric wearable blood pressure monitoring device and left ventricular mass index in working hypertensive patients

Morning Home Blood Pressure and Cardiovascular Events in Japanese Hypertensive Patients. Hypertension

Predictive power of home blood pressure measurement for cardiovascular outcomes in patients with type 2 diabetes: kAMOGAWA-HBP study

Nocturnal blood pressure measured by home devices: evidence and perspective for clinical application

Isolated nocturnal hypertension: a disease masked in the dark

Preventing and managing hypertension: do not forget the night

Nocturnal Hypertension: new Technology and Evidence

Nocturnal Hypertension and Heart Failure: mechanisms, Evidence, and New Treatments

Obstructive Sleep Apnea-Induced Neurogenic Nocturnal Hypertension: a Potential Role of Renal Denervation?

Nighttime Blood Pressure Phenotype and Cardiovascular Prognosis: practitioner-Based Nationwide JAMP Study

Nighttime home blood pressure as a mediator of N-terminal pro-brain natriuretic peptide in cardiovascular events

Sleep and cardiovascular outcomes in relation to nocturnal hypertension: the J-HOP Nocturnal Blood Pressure Study

Simultaneous self-monitoring comparison of a supine algorithm-equipped wrist nocturnal home blood pressure monitoring device with an upper arm device

Accurate nighttime blood pressure monitoring with less sleep disturbance

Cardiovascular Event Risks Associated With Masked Nocturnal Hypertension Defined by Home Blood Pressure Monitoring in the J-HOP Nocturnal Blood Pressure Study

Nighttime Blood Pressure Measured by Home Blood Pressure Monitoring as an Independent Predictor of Cardiovascular Events in General Practice

Direct Comparison of Home Versus Ambulatory Defined Nocturnal Hypertension for Predicting Cardiovascular Events: the Japan Morning Surge-Home Blood Pressure

The relationship between home blood pressure measurement and room temperature in a Japanese general population

The shifted focus of interest in the temperatureblood pressure relationship: from load to variability

The influence of the ambient temperature on blood pressure and how it will affect the epidemiology of hypertension in Asia

Seasonal variation in blood pressure: evidence, consensus and recommendations for clinical practice. Consensus statement by the European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability

Health effects of seasonal variation in cardiovascular hemodynamics among workers in forest environments

Impact of indoor temperature instability on diurnal and day-by-day variability of home blood pressure in winter: a nationwide Smart Wellness Housing survey in Japan

Blood pressure management in an ecosystem context. Hypertens Res

Seasonal variation in blood pressure: current evidence and recommendations for hypertension management

Seasonal Variation of Home Blood Pressure and Its Association With Target Organ Damage: the J-HOP Study (Japan Morning Surge-Home Blood Pressure)

Relationship Between Home Blood Pressure and the Onset Season of Cardiovascular Events: the J-HOP Study (Japan Morning Surge-Home Blood Pressure)

Caution for winter morning surge in blood pressure: a possible link with cardiovascular risk in the elderly

Use of dihydropyridine calcium channel blockers in the management of hypertension in Eastern Asians: a scientific statement from the Asian Pacific Heart Association

Antihypertensive effects and safety of esaxerenone in patients with moderate kidney dysfunction

Effect of esaxerenone on nocturnal blood pressure and natriuretic peptide in different dipping phenotypes

Mineralocorticoid receptor blockers for moderate kidney dysfunction: more merit than ever?

Management of hyperkalemia during treatment with mineralocorticoid receptor blockers: findings from esaxerenone

Role of neprilysin inhibitor combinations in hypertension: insights from hypertension and heart failure trials

Efficacy and safety of LCZ696, a firstin-class angiotensin receptor neprilysin inhibitor, in Asian patients with hypertension: a randomized, double-blind, placebo-controlled study

Angiotensin receptor neprilysin inhibitor as a novel antihypertensive drug: evidence from Asia and around the globe

Differential impact of antihypertensive drugs on cardiovascular remodeling: a review of findings and perspectives for HFpEF prevention

Effects of Sacubitril/Valsartan Versus Olmesartan on Central Hemodynamics in the Elderly With Systolic Hypertension: the PARAMETER Study

Angiotensin receptor-neprilysin inhibitors: comprehensive review and implications in hypertension treatment

Efficacy of sacubitril/valsartan versus olmesartan in Japanese patients with essential hypertension: a randomized, double-blind, multicenter study

Hypertension in diabetes care: emerging roles of recent hypoglycemic agents

Are SGLT2 Inhibitors New Hypertension Drugs?

24-Hour Blood Pressure-Lowering Effect of an SGLT-2 Inhibitor in Patients with Diabetes and Uncontrolled Nocturnal Hypertension: results from the Randomized

Effects of SGLT2 inhibitors on eGFR in type 2 diabetic patients-the role of antidiabetic and antihypertensive medications

Control of 24-hour blood pressure with SGLT2 inhibitors to prevent cardiovascular disease

Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study

World Heart Federation Roadmap for Hypertension -A 2021 Update

Impact of a Workplace Health Promotion Program on Employees' Blood Pressure in a Public University

Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: a population-based observation in Ohasama

Measurement Month 2019: the Global Blood Pressure Screening Campaign of the International Society of Hypertension

Hypertension and related diseases in the era of COVID-19: a report from the Japanese Society of Hypertension Task Force on COVID-19

Telemedicine in the management of hypertension: evolving technological platforms for blood pressure telemonitoring

The current state and future of internet technology-based hypertension management in Japan

The first study comparing a wearable watch-type blood pressure monitor with a conventional ambulatory blood pressure monitor on in-office and out-of-office settings

Evidence and Recommendations on the Use of Telemedicine for the Management of Arterial Hypertension

The dawning of the digital era in the management of hypertension

Perspectives of patients and physicians regarding hypertensive management from an online survey for excellence: a subanalysis of the PARADOX study by physician categories

Physician and patient perspectives on hypertension management and factors associated with lifestyle modifications in Japan: results from an online survey

Treatment-resistant hypertension assessed by home blood pressure monitoring: a new target for intervention?

Association of treatment-resistant hypertension defined by home blood pressure monitoring with cardiovascular outcome

A Japan nationwide web-based survey of patient preference for renal denervation for hypertension treatment

Renal Denervation in Asia: consensus Statement of the Asia Renal Denervation Consortium

Perspectives of renal denervation from hypertension to heart failure in Asia

Renal denervation based on experimental rationale

Long-term outcomes after renal denervation in an Asian population: results from the Global SYMPLICITY Registry in South Korea (GSR Korea)

Catheter-based ultrasound renal denervation in patients with resistant hypertension: the randomized, controlled REQUIRE trial

Effects of renal denervation on blood pressures in patients with hypertension: a systematic review and meta-analysis of randomized sham-controlled trials

Management of Hypertension in the Digital Era: small Wearable Monitoring Devices for Remote Blood Pressure Monitoring

Seven-action approaches for the management of hypertension in Asia -The HOPE Asia network